1-10 of 10
Vasile Musteata
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

SGR-1505, a potent and selective MALT1 inhibitor with preliminary efficacy in BTKi exposed Waldenström macroglobulinemia (WM) and “double-exposed” CLL/SLL

Free
Stephen Spurgeon, Vincent Ribrag, Vasile Musteata, Oksana Karnabeda, Mengyang Di, Nashat Gabrail, Guru Subramanian Guru Murthy, Laura Calustian, Erin Mulvey, Michal Taszner, Sen Zhang, Wu Yin, Min Ye, Frank Basile, Netonia Marshall, Wenxin Zheng, Brian Yoo, Allison Upalawanna, Margaret Dugan, Karen Akinsanya, Matthew Ulrickson, Ciprian Tomuleasa, Carlo Visco, Adam Olszewski
Journal: Blood
Blood (2025) 146 (Supplement 1): 3603.
https://doi.org/10.1182/blood-2025-3603
Published: 2025
Journal Articles

Molecular genetics configuration of chronic myeloid leukemia

Free
Vasile Musteata
Journal: Blood
Blood (2025) 146 (Supplement 1): 7304.
https://doi.org/10.1182/blood-2025-7304
Published: 2025
Journal Articles

Management Milestones in Chronic Myeloid Leukemia Associated with Covid-19

Free
Vasile Musteata, Daniel Coriu, Sr., Jorge E. Cortes
Journal: Blood
Blood (2024) 144 (Supplement 1): 6587.
https://doi.org/10.1182/blood-2024-199932
Published: 2024
Journal Articles

Acute Non-Lymphoblastic Leukemias Presenting with Gingival Hyperplasia: Diagnosis and Management Updates

Free
Vasile Musteata, Sergiu Ciobanu, Olesea Musteata, Gheorghe Nicolau
Journal: Blood
Blood (2023) 142 (Supplement 1): 5860.
https://doi.org/10.1182/blood-2023-180451
Published: 2023
Journal Articles

Management of Patients with Treatment-Free Remission in Chronic Myeloid Leukemia

Free
Vasile Musteata, Sr., Stela Pinzari, Nina Sghibneva-Bobeico
Journal: Blood
Blood (2022) 140 (Supplement 1): 12228.
https://doi.org/10.1182/blood-2022-164480
Published: 2022
Journal Articles

Diagnosis Issues and Management of Nasopharyngeal Non-Hodgkin Lymphomas

Free
Vasile Musteata, Sr., Lilian Nichifor, Larisa Musteata, Galina Durbailova
Journal: Blood
Blood (2021) 138 (Supplement 1): 4588.
https://doi.org/10.1182/blood-2021-144340
Published: 2021
Journal Articles

A Phase 2 Study of MT-3724 to Evaluate Safety, Pharmacodynamics and Efficacy of MT-3724 for the Treatment of Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Free
Daniel O. Persky, MD, Vasile Musteata, MD PhD, Mamia Zodelava, MD, Tetiana Perekhrestenko, MD PhD, Adolfo E Diaz, MD, Troy H. Guthrie, Jr., MD, Thomas Strack, MD, Christine Burnett, Sarah Wilson, CCRA, Tara Baetz, MD FRCPC
Journal: Blood
Blood (2019) 134 (Supplement_1): 5324.
https://doi.org/10.1182/blood-2019-128604
Published: 2019
Journal Articles

Monotherapy Activity with the First CD20-Targeted Immunotoxin, MT-3724, in Subjects with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)

Free
Paul A. Hamlin, MD, Vasile Musteata, MD PhD, Mamia Zodelava, MD, Steven I Park, MD, Christine Burnett, Kristina Dabovic, PharmD, Eric T Williams, PhD, Jack P Higgins, PhD, Daniel O. Persky, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4098.
https://doi.org/10.1182/blood-2019-129243
Published: 2019
Journal Articles

Rozanolixizumab, an Anti-FcRn Antibody: Final Results from a Phase II, Multiple-Dose Study in Patients with Primary Immune Thrombocytopenia

Free
Tadeusz Robak, MD, Maciej Kaźmierczak, Isidro Jarque, Vasile Musteata, MD PhD, Jacek Trelinski, Nichola Cooper, MD MRCP, Peter Kiessling, Ute Massow, Franz Woltering, Rose Snipes, Juan Ke, Grant Langdon, Birgit Haier, James B. Bussel, MD, Stephen Jolles
Journal: Blood
Blood (2019) 134 (Supplement_1): 897.
https://doi.org/10.1182/blood-2019-129839
Published: 2019
Journal Articles

Phase II, Multiple-Dose Study of Anti-FcRn Antibody, Rozanolixizumab (UCB7665), in Patients with Primary Immune Thrombocytopenia: Interim Analysis

Free
Tadeusz Robak, Isidro Jarque, Vasile Musteata, Peter Kiessling, Ute Massow, James Higginson, Rose Snipes, Stephen Jolles
Journal: Blood
Blood (2017) 130 (Supplement 1): 15.
https://doi.org/10.1182/blood.V130.Suppl_1.15.15
Published: 2017